MUC2 and irritable bowel syndrome: Inflammatory bowel disease (IBD) represents a chronic relapsing/remitting inflammatory disease of the gastrointestinal tract previously shown to exhibit altered O-glycosylation profiles on tissue-extracted MUC2 (27).